FDAnews Device Daily Bulletin

LEFT VENTRICULAR ASSISTANT DEVICES EXTEND LIVES OF PATIENTS TOO SICK FOR TRANSPLANT

Nov. 29, 2005
A A

Pumps implanted into the chest to maintain circulation can significantly extend the lives of the sickest patients in end-stage heart failure who are not candidates for heart transplantation, according to the results of a clinical trial led by Duke University Medical Center cardiologists. The pumps, known as left ventricular assistant devices (LVADs), are employed when the heart's left ventricle -- the chamber of the heart that pumps blood throughout the body -- is too weak to pump enough blood to nourish the body's tissues. LVADs have been used as successful short-term "bridges to heart transplant" and are increasingly being considered as a long-term heart failure destination therapy, said the researchers.

NewsMedical.net (http://www.news-medical.net/print_article.asp?id=14682)